30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Kuros Biosciences Begins Trial of MagnetOs in Spinal Fusion -

Kuros Biosciences commenced an investigator-led multicenter study comparing MagnetOs bone graft substitute vs. autologous bone in posterolateral spinal fusion. The blinded, controlled, randomized multicenter trial will enroll 100 patients in the Netherlands, starting in 2H18. The primary objective is to demonstrate non-inferiority in efficacy and safety of MagnetOs. (Kuros Biosciences, 6/12/18)